Volume | 32,493 |
|
|||||
News | - | ||||||
Day High | 3.10 | Low High |
|||||
Day Low | 2.9601 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
LAVA Therapeutics NV | LVTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.10 | 2.9601 | 3.10 | 3.10 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
205 | 32,493 | US$ 3.04 | US$ 98,765 | - | 1.131 - 6.47 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:58:44 | 5 | US$ 3.0523 | USD |
LAVA Therapeutics NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
79.92M | 26.29M | - | 6.77M | -41.97M | -1.60 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
LAVA Therapeutics NV News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LVTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.70 | 3.10 | 2.68 | 2.92 | 93,225 | 0.3599 | 13.33% |
1 Month | 2.95 | 3.57 | 2.51 | 2.97 | 160,952 | 0.1099 | 3.73% |
3 Months | 1.68 | 6.47 | 1.6626 | 3.03 | 1,175,380 | 1.38 | 82.14% |
6 Months | 1.23 | 6.47 | 1.16 | 2.67 | 947,389 | 1.83 | 148.77% |
1 Year | 1.55 | 6.47 | 1.131 | 2.61 | 637,466 | 1.51 | 97.41% |
3 Years | 11.88 | 16.20 | 1.131 | 3.36 | 307,749 | -8.82 | -74.24% |
5 Years | 11.48 | 17.20 | 1.131 | 3.55 | 303,142 | -8.42 | -73.35% |
LAVA Therapeutics NV Description
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. |